NeuroBo Pharmaceuticals
pharmaceuticals developing and commercializing multimodal disease modifying therapies for viral neuropathic and neurodegenerative diseases a disease | NeuroBo Pharmaceuticals
Deck date
March 2021
Slide
3 of 27
Other recent decks by NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Investor Presentation
December 2023
Securities Offering
October 2022
Search Thousands of Presentations by World Leading Companies